尤峥因工作调整原因辞去赛力斯公司第五届董事会非执行董事职务。尤峥未持有赛力斯公司股份。 赛力斯公司董事会同意提名杨彦鼎为公司第五届董事会非执行董事候选人，任期自公司股东会审议通过 之日起至第五届董事会任期届满。 作者丨彭鑫 编辑丨安安 近日，赛力斯集团股份有限公司发布《关于非执行董事变更的公告》（公告编号2025-105）称，公司于 近日收到股东东风汽车集团有限公司《关于尤峥、杨彦鼎两人职务任免的函》，并收到尤峥向赛力斯提 交的书面辞职报告。 ...

Core Insights - The article highlights the rise of Zhejiang University entrepreneurs, particularly focusing on the innovative strides made by TreeLan Medical Group under the leadership of Zheng Jie, emphasizing a dual-driven strategy of healthcare and technology [1][3]. Company Overview - TreeLan Medical Group has evolved into a technology-driven healthcare organization that integrates health services, medical research, and education, establishing a comprehensive service model from treatment to health management [1][3]. - Zheng Jie, the founder and chairman, emphasizes a commitment to a long-term vision that transcends short-term gains, aiming to redefine healthcare services through technology [1][3]. Technological Integration - The company has developed a proprietary Hospital Information System (HIS) to digitize core medical processes, enhancing service quality and patient experience [3][4]. - TreeLan Medical has positioned itself to leverage AI technologies, with a focus on creating an AI future hospital that redefines the boundaries of medical services [1][5]. AI Applications - The introduction of AI health assistant Dr.Shu aims to streamline the patient journey from symptom consultation to appointment scheduling, enhancing the overall healthcare experience [6][8]. - The AI pathology assistant significantly reduces diagnosis time by automating the analysis of pathology slides, improving diagnostic accuracy and efficiency [7][9]. Future Vision - TreeLan Medical is committed to building an "AI future medical institution" with a focus on integrating AI and wearable technologies to enhance healthcare delivery across various settings [12][13]. - The company aims to establish a comprehensive health management relationship with patients, providing services that span prevention, diagnosis, treatment, and rehabilitation [13][15]. Industry Context - The article discusses the broader implications of AI in healthcare, highlighting government initiatives aimed at promoting AI applications in medical settings, which align with TreeLan's strategic direction [5][11]. - The establishment of the Open Medical and Healthcare Alliance (OMAHA) aims to enhance data interoperability and support the digital transformation of healthcare [11].

Core Insights - The home appliance industry is currently in a stock competition phase, where companies typically engage in price wars and marketing battles to gain market share. However, Haier Smart Home has demonstrated a different approach, achieving significant revenue and profit growth while reducing sales expenses [1][4]. Group 1: Financial Performance - Haier Smart Home's revenue increased from 227.1 billion yuan in 2021 to 285.9 billion yuan in 2024, a growth of 58.8 billion yuan [1][3]. - The company's profit rose from 13.067 billion yuan in 2021 to 18.741 billion yuan in 2024, an increase of approximately 5.7 billion yuan [1][3]. - Sales expense ratio decreased from 16.1% in 2021 to 11.7% in 2024, a reduction of 4.4 percentage points [3][4]. - Absolute sales expenses fell from 36.5 billion yuan in 2021 to 33.5 billion yuan in 2024, a decrease of 3 billion yuan [3][4]. Group 2: Cost Reduction Strategies - Haier Smart Home achieved cost reduction through comprehensive digital transformation across all processes, including R&D, manufacturing, supply chain, marketing, logistics, and service [4][5]. - The company improved logistics efficiency by increasing direct delivery from company to user, with 74% of orders from county specialty stores being directly delivered to users by the end of September [4][5]. - Global brand and channel expansion has reached a harvest period, leading to reduced costs in overseas sales as the brand matrix is now well-established [4][5]. Group 3: Product Strategy and Innovation - The company focuses on high-end brands and product suites, which enhance pricing power while lowering costs. For instance, the Casarte brand saw an 18% revenue growth in the first three quarters, leading in the high-end appliance market [5][6]. - The sales proportion of Casarte suite products increased to 36%, up 7% year-on-year, while Haier brand suite products rose to 15%, up 11% year-on-year [5][6]. - R&D investment has consistently increased from 8.364 billion yuan in 2021 to 10.74 billion yuan in 2024, indicating a significant annual growth rate [5][6].

Group 1 - The company Jiangzhong Pharmaceutical Co., Ltd. has announced a name change to China Resources Jiangzhong Pharmaceutical Co., Ltd. to enhance brand recognition and market influence [1][4] - The stock abbreviation will change to "华润江中" while the stock code remains unchanged [1][4] - The name change is part of a broader strategy following the acquisition by China Resources Group, which has been progressively taking control of Jiangzhong Group since 2018 [1][2] Group 2 - The decision to change the company name was approved during the 10th meeting of the 10th Board of Directors, with unanimous support from the board members [3] - The company aims to strengthen brand synergy with China Resources, which is expected to improve its market presence [1][4]

#同仁堂南极磷虾油磷脂含量为0被约谈#【#同仁堂南极磷虾油磷脂含量为0#】#不含磷脂的磷虾油实为 同仁堂贴牌产品#日前，上海市消保委公众号发布文章称，已经约谈疑似造假的南极磷虾油生产商，背 后涉及知名企业、老字号品牌"同仁堂"。 据上海市消保委公众号，一款标称"北京同仁堂99%高纯南极磷虾油"的产品，在网页上写着"高含 量"、"智利进口原料"、"高度提纯"、"1粒≈100只磷虾"，其磷脂标识值为43%，看似是品质出众的优质 产品，但检测结果显示该款产品磷脂含量为0。 专家表示，南极磷虾油产品应该是以南极磷虾为原料提取的虾油，必定含有磷脂成分。针对相关企业涉 嫌造假行为，为了保护消费者合法权益，上海市消保委将于近日约谈该产品的生产企业安徽哈博药业有 限公司和经销商北京同仁堂（四川）健康药业有限公司，要求其对产品的真实情况做出解释。 第一财经记者注意到，北京同仁堂（四川）健康药业有限公司销售的这款南极磷虾油其实可以视作北京 同仁堂的"贴牌"产品，该公司是中国北京同仁堂（集团）有限责任公司的"孙公司"。 此前网上关于"同仁堂"没有双龙标的争议已经发酵。包括北京同仁堂（四川）健康药业有限公司在内的 厂家销售的所谓"同 ...

Group 1 - The core viewpoint of the news is that the new quantity control policy by Kweichow Moutai has led to a significant increase in market prices for its products, with reports of prices rising over 150 yuan per bottle in certain regions [1][2] - Following the announcement of the new policy, the wholesale price of Moutai in Tianjin has surged to 1,630 yuan per bottle, reflecting a two-day increase of over 150 yuan [1] - The retail price in some Beijing smoke shops has returned to 1,680 yuan per bottle, indicating a broader impact on the market due to the price adjustments [1] Group 2 - Kweichow Moutai's short-term measures include halting the distribution of all Moutai products to distributors until January 1, 2026, to alleviate financial pressure on distributors during a tight cash flow period [2] - The long-term structural reform plan involves a significant reduction in the quotas for non-standard products, with specific cuts of 30% for 15-year and 1-liter Flying Moutai, and a 50% reduction for Zodiac Moutai, while completely stopping the supply of colored glaze premium Moutai [2] - Although distributors still have a profit margin with a purchase price of 1,169 yuan per bottle compared to the market price of around 1,600 yuan, the overall cost for distributors remains high due to the inclusion of various products in their quotas [2]

此外据媒体报道，今年上半年茅台管理层曾与京东、阿里达成共识，要求"电商渠道主动融入茅台渠道 生态，反对不正当竞争"。 前不久在三季度业绩说明会上，茅台集团总经理、贵州茅台代总经理王莉也透露，当前茅台正在努力与 各大网络平台建立假冒侵权信息绿色处置通道，配合各级市场监管部门推动协同共治。 回顾2025年以来的市场走势，飞天茅台零售价格呈现出单边下行态势。6月11日散瓶批发价首次跌破 2000元心理关口后，降价通道正式开启：6月22日跌至1900元以下，6月25日再破1800元，虽7月7日短暂 反弹至1880元，但8月29日再度失守1800元，10月底跌破1700元，11月末跌破1600元。 【#经销商称茅台1天上调4次价格#】近日，据媒体报道，贵州茅台酒价出现明显异动。有深圳经销商透 露，2025年飞天茅台酒的价格在一天之内上调了4次价格。12月13日傍晚，拿货价格为1580元/瓶。北方 某省的渠道经销商亦证实了这一点。 二级市场方面，截至12月12日，贵州茅台(600519.SH)股价收报1420.65元/股，总市值17790亿元。（21 财经） 贵州茅台(600519) < 白 闭市 12-12 15:00 ...

【#郭沫若女儿要求终止拍卖父亲书法手卷#《蜀道奇》：作品系遗失，已报警】#郭沫若女儿称拍卖品 系遗失私藏已报警#近日，郭沫若书法手卷《蜀道奇》将亮相北京保利二十周年秋拍，12月16日开拍， 起拍价800万元。其女郭庶英委托律师发布声明，称该作品为父亲1961年题赠自己的私藏，从未转让或 授权，目前已遗失并报警，质疑拍卖为无权处分，要求保利中止拍卖、返还作品。 北京市京都律师事务所(以下简称"本所")接受郭庶英女士(以 下简称"委托人")的专项委托,现就其享有所有权的郭沫若先生书 法作品《蜀道奇》手卷(以下简称"该作品")被不明第三方擅自委 托拍卖一事,郑重声明如下: 一、事实与权属主张 该作品系郭沫若先生于 1961年10月14日创作,并题款"書付 庶英"赠与委托人。自受赠以来,委托人长期合法持有并保管该作品。 根据委托人陈述及现有相关证据,本所律师认为,郭庶英女士系该作 品唯一的合法所有权人。 记者查询发现，截至12月12日，保利拍卖官网仍未撤下该拍品，其信息显示作品 "传承有序、原装原 裱"，为郭沫若自作诗手卷，在拍卖市场极为罕见。郭庶英方面透露，曾与保利沟通但遭拒绝，对方坚 持委托人有权处分。据业内人士 ...

Core Viewpoint - Company announced the completion of certain fundraising projects, specifically the "Factory Intelligent Upgrade and Electric Drive Production Line Construction Project," which has reached the predetermined usable status, allowing for the reallocation of surplus funds amounting to 19,462 million yuan to the "Electrification Vehicle Development and Product Platform Technology Upgrade Project" [1] Group 1 - The company has completed the "Factory Intelligent Upgrade and Electric Drive Production Line Construction Project" [1] - Surplus funds of 19,462 million yuan will be redirected to the "Electrification Vehicle Development and Product Platform Technology Upgrade Project" [1] - The company plans to adjust the internal investment structure for the 2022 non-public offering projects, extending the usable status date for the "User Center Construction Project" and "Electrification Vehicle Development and Product Platform Technology Upgrade Project" to December 2027 [1]

12月12日，长安汽车（000625）公告称，其控股子公司深蓝汽车拟以公开挂牌方式增资扩股，预计募资 规模约61.22亿元，包括重庆产交所公开挂牌增资和非公开协议增资两部分。 其中，长安汽车拟以非公开协议方式通过无形资产加自有资金合计增资不超过31.22亿元。本次交易构 成关联交易，尚需获得股东会批准。 ...